{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:55:34Z","timestamp":1790999734011,"version":"4.1.0"},"reference-count":43,"publisher":"Japanese Society of Veterinary Science","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1292\/jvms.25-0431","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T22:11:13Z","timestamp":1787091073000},"page":"1592-1602","source":"Crossref","is-referenced-by-count":0,"title":["Comparative analysis of the cardiotoxicity induced by doxorubicin and epirubicin and exploratory investigations of clinical parameters indicating the cardiotoxicity in healthy dogs"],"prefix":"10.1292","volume":"88","author":[{"given":"Shotaro","family":"SHIMANO","sequence":"first","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"TOMIYASU","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"ISHIKAWA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pathology, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"SAKUMA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"TOYODA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"MATSUMURA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehito","family":"UCHIKURA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"INAZUMI","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"NAMIKI","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"NAKASE","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"TSURUTA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"NAKAMURA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"MIURA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuma","family":"NAGAO","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"TOCHINAI","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pathophysiology and Animal Health, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K","family":"CHAMBERS","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pathology, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"UCHIDA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pathology, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"MIZUNO","sequence":"additional","affiliation":[{"name":"Veterinary Medical Center, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"GOTO-KOSHINO","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"OKUDA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Askin L, Yuce E\u0130, Tanriverdi O.  2023. Myocardial performance index and cardiovascular diseases. <i>Echocardiography<\/i> 40: 720\u2013725.","DOI":"10.1111\/echo.15628"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bertazzoli C, Rovero C, Ballerini L, Lux B, Balconi F, Antongiovanni V, Magrini U.  1985. Experimental systemic toxicology of 4\u2032-epidoxorubicin, a new, less cardiotoxic anthracycline antitumor agent. <i>Toxicol Appl Pharmacol<\/i> 79: 412\u2013422.","DOI":"10.1016\/0041-008X(85)90139-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bertinchant JP, Polge A, Juan JM, Oliva-Lauraire MC, Giuliani I, Marty-Double C, Burdy JY, Fabbro-Peray P, Laprade M, Bali JP, Granier C, de la Coussaye JE, Dauzat M.  2003. Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and histological findings. <i>Clin Chim Acta<\/i> 329: 39\u201351.","DOI":"10.1016\/S0009-8981(03)00013-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Boczar KE, Aseyev O, Sulpher J, Johnson C, Burwash IG, Turek M, Dent S, Dwivedi G.  2016. Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy. <i>Echo Res Pract<\/i> 3: 79\u201384.","DOI":"10.1530\/ERP-16-0020"},{"key":"5","unstructured":"5. Boon JA.  2011. Veterinary Echocardiography, 2nd ed., Wiley-Blackwell, Hoboken."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Boon JA.  2016. Measurement and assessment of two-dimensional and M-mode images. pp. 83\u2013105. In: Two\u2010dimensional and M\u2010mode Echocardiography for the Small Animal Practitioner (Boon JA ed.), Wiley, Hoboken.","DOI":"10.1002\/9781119028574.ch6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Boon J, Wingfield WE, Miller CW.  1983. Echocardiographic indices in the normal dog. <i>Vet Radiol<\/i> 24: 214\u2013221.","DOI":"10.1111\/j.1740-8261.1983.tb00718.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Calleja A, Poulin F, Khorolsky C, Shariat M, Bedard PL, Amir E, Rakowski H, McDonald M, Delgado D, Thavendiranathan P.  2015. Right ventricular dysfunction in patients experiencing cardiotoxicity during breast cancer therapy. <i>J Oncol<\/i> 2015: 609194.","DOI":"10.1155\/2015\/609194"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Chan J, Shiino K, Obonyo NG, Hanna J, Chamberlain R, Small A, Scalia IG, Scalia W, Yamada A, Hamilton-Craig CR, Scalia GM, Zamorano JL.  2017. Left ventricular global strain analysis by two-dimensional speckle-tracking echocardiography: the learning Curve. <i>J Am Soc Echocardiogr<\/i> 30: 1081\u20131090.","DOI":"10.1016\/j.echo.2017.06.010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Edwalds GM, Said JW, Block MI, Herscher LL, Siegel RJ, Fishbein MC.  1984. Myocytolysis (vacuolar degeneration) of myocardium: immunohistochemical evidence of viability. <i>Hum Pathol<\/i> 15: 753\u2013756 .","DOI":"10.1016\/S0046-8177(84)80166-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Elliott JW, Cripps P, Marrington AM, Grant IA, Blackwood L.  2013. Epirubicin as part of a multi-agent chemotherapy protocol for canine lymphoma. <i>Vet Comp Oncol<\/i> 11: 185\u2013198.","DOI":"10.1111\/j.1476-5829.2011.00311.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ewer MS, Ali MK, Mackay B, Wallace S, Valdivieso M, Legha SS, Benjamin RS, Haynie TP.  1984. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin. <i>J Clin Oncol<\/i> 2: 112\u2013117 .","DOI":"10.1200\/JCO.1984.2.2.112"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ewer MS, Lenihan DJ.  2008. Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?<i>J Clin Oncol<\/i> 26: 1201\u20131203.","DOI":"10.1200\/JCO.2007.14.8742"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fallah-Rad N, Walker JR, Wassef A, Lytwyn M, Bohonis S, Fang T, Tian G, Kirkpatrick IDC, Singal PK, Krahn M, Grenier D, Jassal DS.  2011. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. <i>J Am Coll Cardiol<\/i> 57: 2263\u20132270.","DOI":"10.1016\/j.jacc.2010.11.063"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Friedman MA, Bozdech MJ, Billingham ME, Rider AK.  1978. Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals. <i>JAMA<\/i> 240: 1603\u20131606.","DOI":"10.1001\/jama.1978.03290150049023"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gallay-Lepoutre J, B\u00e9langer MC, Nadeau ME.  2016. Prospective evaluation of Doppler echocardiography, tissue Doppler imaging and biomarkers measurement for the detection of doxorubicin-induced cardiotoxicity in dogs: A pilot study. <i>Res Vet Sci<\/i> 105: 153\u2013159.","DOI":"10.1016\/j.rvsc.2016.02.001"},{"key":"17","unstructured":"17. Gillings S, Johnson J, Fulmer A, Hauck M.  2009. Effect of a 1-hour IV infusion of doxorubicin on the development of cardiotoxicity in dogs as evaluated by electrocardiography and echocardiography. <i>Vet Ther<\/i> 10: 46\u201358."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hallman BE, Hauck ML, Williams LE, Hess PR, Suter SE.  2019. Incidence and risk factors associated with development of clinical cardiotoxicity in dogs receiving doxorubicin. <i>J Vet Intern Med<\/i> 33: 783\u2013791.","DOI":"10.1111\/jvim.15414"},{"key":"19","unstructured":"19. Herman EH, Lipshultz SE, Rifai N, Zhang J, Papoian T, Yu ZX, Takeda K, Ferrans VJ.  1998. Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity. <i>Cancer Res<\/i> 58: 195\u2013197."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ho E, Brown A, Barrett P, Morgan RB, King G, Kennedy MJ, Murphy RT.  2010. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. <i>Heart<\/i> 96: 701\u2013707.","DOI":"10.1136\/hrt.2009.173997"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kim SE, Liptak JM, Gall TT, Monteith GJ, Woods JP.  2007. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997\u20132004). <i>J Am Vet Med Assoc<\/i> 231: 1550\u20131557.","DOI":"10.2460\/javma.231.10.1550"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. LeBlanc AK, Atherton M, Bentley RT, Boudreau CE, Burton JH, Curran KM, Dow S, Giuffrida MA, Kellihan HB, Mason NJ, Oblak M, Selmic LE, Selting KA, Singh A, Tjostheim S, Vail DM, Weishaar KM, Berger EP, Rossmeisl JH, Mazcko C.  2021. Veterinary cooperative oncology group-common terminology criteria for adverse events (VCOG-CTCAE v2) following investigational therapy in dogs and cats. <i>Vet Comp Oncol<\/i> 19: 311\u2013352.","DOI":"10.1111\/vco.12677"},{"key":"23","unstructured":"23. Loar AS, Susaneck SJ.  1986. Doxorubicin-induced cardiotoxicity in five dogs. <i>Semin Vet Med Surg (Small Anim)<\/i> 1: 68\u201371."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH, ESC Scientific Document Group. 2022. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). <i>Eur Heart J<\/i> 43: 4229\u20134361.","DOI":"10.1714\/3967.39463"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Marrington AM, Killick DR, Grant IA, Blackwood L.  2012. Toxicity associated with epirubicin treatments in a large case series of dogs. <i>Vet Comp Oncol<\/i> 10: 113\u2013123.","DOI":"10.1111\/j.1476-5829.2011.00281.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mauldin GE, Fox PR, Patnaik AK, Bond BR, Mooney SC, Matus RE.  1992. Doxorubicin-induced cardiotoxicosis. Clinical features in 32 dogs. <i>J Vet Intern Med<\/i> 6: 82\u201388.","DOI":"10.1111\/j.1939-1676.1992.tb03156.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Mercuro G, Cadeddu C, Piras A, Dess\u00ec M, Madeddu C, Deidda M, Serpe R, Massa E, Mantovani G.  2007. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers. <i>Oncologist<\/i> 12: 1124\u20131133.","DOI":"10.1634\/theoncologist.12-9-1124"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, Galderisi M, Marwick T, Nagueh SF, Sengupta PP, Sicari R, Smiseth OA, Smulevitz B, Takeuchi M, Thomas JD, Vannan M, Voigt JU, Zamorano JL.  2011. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE\/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. <i>J Am Soc Echocardiogr<\/i> 24: 277\u2013313.","DOI":"10.1016\/j.echo.2011.01.015"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Morita T, Uchida N, Kimura M.  2024. Effects of chemotherapy treatment with doxorubicin on right ventricular function in dogs. <i>J Vet Med Sci<\/i> 86: 885\u2013891.","DOI":"10.1292\/jvms.24-0004"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Nagiub M, Nixon JV, Kontos MC.  2018. Ability of nonstrain diastolic parameters to predict doxorubicin-induced cardiomyopathy: a systematic review with meta-analysis. <i>Cardiol Rev<\/i> 26: 29\u201334.","DOI":"10.1097\/CRD.0000000000000161"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Negishi T, Negishi K.  2018. Echocardiographic evaluation of cardiac function after cancer chemotherapy. <i>J Echocardiogr<\/i> 16: 20\u201327.","DOI":"10.1007\/s12574-017-0344-6"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ng R, Better N, Green MD.  2006. Anticancer agents and cardiotoxicity. <i>Semin Oncol<\/i> 33: 2\u201314.","DOI":"10.1053\/j.seminoncol.2005.11.001"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Pino EHM, Weber MN, de Oliveira LO, Vieira LC, Dos Santos KHS, Liu IP, Gomes HM, Trindade-Gerardi AB, Moreira JCF, Gerardi DG.  2021. Evaluation of cardioprotective effects of carvedilol in dogs receiving doxorubicin chemotherapy: A prospective, randomized, double-blind, placebo controlled pilot study. <i>Res Vet Sci<\/i> 135: 532\u2013541.","DOI":"10.1016\/j.rvsc.2020.11.007"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Plosker GL, Faulds D.  1993. Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy. <i>Drugs<\/i> 45: 788\u2013856.","DOI":"10.2165\/00003495-199345050-00011"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Singal PK, Iliskovic N.  1998. Doxorubicin-induced cardiomyopathy. <i>N Engl J Med<\/i> 339: 900\u2013905.","DOI":"10.1056\/NEJM199809243391307"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Song B, Wang BN, Chen DN, Luo ZG.  2013. Myocardial remodeling and bioelectric changes in tachycardia-induced heart failure in dogs. <i>Braz J Med Biol Res<\/i> 46: 797\u2013802.","DOI":"10.1590\/1414-431X20132694"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Tanaka R, Umemura M, Narikawa M, Hikichi M, Osaw K, Fujita T, Yokoyama U, Ishigami T, Tamura K, Ishikawa Y.  2020. Reactive fibrosis precedes doxorubicin-induced heart failure through sterile inflammation. <i>ESC Heart Fail<\/i> 7: 588\u2013603.","DOI":"10.1002\/ehf2.12616"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Tater G, Eberle N, Hungerbuehler S, Joetzke A, Nolte I, Wess G, Betz D.  2017. Assessment of cardiac troponin I (cTnI) and tissue velocity imaging (TVI) in 14 dogs with malignant lymphoma undergoing chemotherapy treatment with doxorubicin. <i>Vet Comp Oncol<\/i> 15: 55\u201364.","DOI":"10.1111\/vco.12135"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Theetha Kariyanna P, Kumar A, Jayarangaiah A, Shetty M, Chowdhury Y, Das S, Jayarangaiah A.  2023. Chemotherapy induced right ventricular cardiomyopathy; a systematic review and meta-analysis. <i>Front Cardiovasc Med<\/i> 10: 1103941.","DOI":"10.3389\/fcvm.2023.1103941"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Wang G, Li J, Bojmar L, Chen H, Li Z, Tobias GC, Hu M, Homan EA, Lucotti S, Zhao F, Posada V, Oxley PR, Cioffi M, Kim HS, Wang H, Lauritzen P, Boudreau N, Shi Z, Burd CE, Zippin JH, Lo JC, Pitt GS, Hernandez J, Zambirinis CP, Hollingsworth MA, Grandgenett PM, Jain M, Batra SK, DiMaio DJ, Grem JL, Klute KA, Trippett TM, Egeblad M, Paul D, Bromberg J, Kelsen D, Rajasekhar VK, Healey JH, Matei IR, Jarnagin WR, Schwartz RE, Zhang H, Lyden D.  2023. Tumour extracellular vesicles and particles induce liver metabolic dysfunction. <i>Nature<\/i> 618: 374\u2013382.","DOI":"10.1038\/s41586-023-06114-4"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Westrup U, McEvoy FJ.  2013. Speckle tracking echocardiography in mature Irish Wolfhound dogs: technical feasibility, measurement error and reference intervals. <i>Acta Vet Scand<\/i> 55: 41.","DOI":"10.1186\/1751-0147-55-41"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Willis R.  2018. Electrocardiography. pp. 35\u201356. In: Guide to Canine and Feline Electrocardiography (Willis R, Oliveira P, Mavropoulou A eds.), Wiley, Hoboken.","DOI":"10.1002\/9781119254355.ch4"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Woicke J, Al-Haddawi MM, Bienvenu JG, Caverly Rae JM, Chanut FJ, Colman K, Cullen JM, Davis W, Fukuda R, Huisinga M, Walker UJ, Kai K, Kovi RC, Macri NP, Marxfeld HA, Nikula KJ, Pardo ID, Rosol TJ, Sharma AK, Singh BP, Tamura K, Thibodeau MS, Vezzali E, Vidal JD, Meseck EK.  2021. International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): nonproliferative and proliferative lesions of the dog. <i>Toxicol Pathol<\/i> 49: 5\u2013109.","DOI":"10.1177\/0192623320968181"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/88\/10\/88_25-0431\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:33:09Z","timestamp":1790998389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/88\/10\/88_25-0431\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.25-0431","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"25-0431"}}